Schaeffer R C, Barnhart M I, Carlson R W
Microvasc Res. 1987 May;33(3):327-52. doi: 10.1016/0026-2862(87)90027-6.
The effects of fibrin microembolism were examined using an infusion of a prothrombin activator (Echis carinatus venom, ECV; 30 min, 0.5 NIH thrombin equivalent units/kg) in acute mongrel dogs prepared with a pulmonary lymph cannula (n = 6, 12.3-21.5 kg). Lymph flow increased approximately 2.5-fold after 1-1.5 hr of elevated left atrial pressure (Pla = 20 cm H2O; 26 +/- 7 to 63 +/- 16 microliter/min, P less than 0.01) and the plasma to lymph protein concentration ratio (CP/CL) declined from 0.66 +/- .04 to 0.54 +/- .16 (P less than 0.01, x +/- SE). After Pla was reduced to control levels, the initiation of fibrin microembolism was associated with an approximate 2.7-fold elevation of lymph flow (62 +/- 8 microliters/min, P less than 0.01) and the CP/CL was not changed (0.56 +/- 0.04, P = ns). When Pla was increased following microembolism, lymph flow more than doubled to 117 +/- 24 microliter/min (P less than 0.01) and the CP/CL remained unaltered (0.56 +/- 0.03, P = ns). These changes were associated with afibrinogenemia and the appearance of fibrin degradation products (FDP) in plasma (150 +/- 50 micrograms/ml) and lymph (80 micrograms/ml) in three of the animals tested. No consistent pattern was seen in the CL/CP of separate endogenous plasma proteins after each intervention. These data support the view that pulmonary fibrin microembolism without inhibition of the fibrinolytic system was associated with an early increased pulmonary microvascular permeability to protein. In a separate group of similarly prepared animals (n = 8, 13-21.5 kg) without a lymph catheter, scanning electron microscopic observations showed branching fibrin microemboli to partially occlude some pulmonary arterioles. Mixed thrombus formations in larger precapillary blood vessels were also seen. Ultrastructural observations revealed the deposition of fibrin strands (periodicity = 220-230 A) within the pulmonary capillaries. Some of these deposits were overlaid by lamellar pseudopodia from endothelial cells and the fibrin appeared to be within these cells. Although plasmalemmal vesicles seemed to be more numerous in the endothelial cells with adjacent fibrin deposits, no gaps or breaks were seen in the densely stained interendothelial cell junctions and/or the endothelial cell membrane of the affected lung capillaries. Activated neutrophils and platelets were more numerous in the pulmonary capillaries following EVC. These data suggest that the presence of FDP and/or fibrin deposits within the pulmonary microvasculature may influence the early functional integrity of pulmonary endothelial cells at sites of fibrin accumulation.
使用凝血酶原激活剂(锯鳞蝰蛇毒,ECV;30分钟,0.5 NIH凝血酶当量单位/千克)对制备了肺淋巴插管的急性杂种犬(n = 6,12.3 - 21.5千克)进行输注,以研究纤维蛋白微栓塞的影响。在左心房压力升高(Pla = 20 cm H2O;从26±7微升/分钟增加到63±16微升/分钟,P < 0.01)1 - 1.5小时后,淋巴流量增加了约2.5倍,血浆与淋巴蛋白浓度比(CP/CL)从0.66±0.04降至0.54±0.16(P < 0.01,x±SE)。当Pla降至对照水平后,纤维蛋白微栓塞的开始与淋巴流量约2.7倍的升高相关(62±8微升/分钟,P < 0.01),且CP/CL未改变(0.56±0.04,P = 无显著差异)。当微栓塞后Pla升高时,淋巴流量增加超过一倍,达到117±24微升/分钟(P < 0.01),且CP/CL保持不变(0.56±0.03,P = 无显著差异)。这些变化与纤维蛋白原血症以及三只受试动物血浆(150±50微克/毫升)和淋巴(80微克/毫升)中纤维蛋白降解产物(FDP)的出现有关。每次干预后,单独的内源性血浆蛋白的CL/CP未观察到一致的模式。这些数据支持这样的观点,即不抑制纤维蛋白溶解系统的肺纤维蛋白微栓塞与早期肺微血管对蛋白质的通透性增加有关。在另一组同样制备但没有淋巴导管的动物(n = 8,13 - 21.5千克)中,扫描电子显微镜观察显示分支的纤维蛋白微栓子部分阻塞了一些肺小动脉。在较大的毛细血管前血管中也观察到混合血栓形成。超微结构观察显示肺毛细血管内有纤维蛋白丝沉积(周期 = 220 - 230 Å)。其中一些沉积物被内皮细胞的层状伪足覆盖,并且纤维蛋白似乎在这些细胞内。尽管在有相邻纤维蛋白沉积物的内皮细胞中质膜小泡似乎更多,但在受影响的肺毛细血管的紧密染色的内皮细胞间连接和/或内皮细胞膜中未观察到间隙或破裂。在ECV处理后,肺毛细血管中活化的中性粒细胞和血小板更多。这些数据表明肺微血管内FDP和/或纤维蛋白沉积物的存在可能会影响纤维蛋白积累部位肺内皮细胞的早期功能完整性。